Uveal Melanoma – Trials in Disease – Overview of Information and Clinical Research
Uveal melanoma is a rare form of eye cancer that can spread to other parts of the body, most commonly the liver.
Uveal melanoma is a rare form of eye cancer that can spread to other parts of the body, most commonly the liver. Currently, 14 clinical trials are testing new treatments for this condition across multiple countries in Europe, investigating targeted therapies, immunotherapies, and combination treatments for patients at different stages of the disease.
This overview highlights ongoing trials that may provide new therapeutic options for patients with localized or metastatic uveal melanoma, a disease with limited current treatment options and a high risk of liver metastasis.
Evidence level: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Related signals
- Beyond the Five-Year Milestone: Long‑term Survivorship of Melanoma Patients Treated Off‑Trial with anti‑PD‑1
- A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
- Melanoma Research
- The Clinical Trial Landscape for Melanoma Therapies
- Melanoma: Pathogenesis and Targeted Therapy